Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,185 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $366.07 | 7 | $0 (2023) |
| Boston Scientific Corporation | $296.27 | 7 | $0 (2022) |
| Echosens North America, Inc. | $200.50 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $166.68 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $85.57 | 1 | $0 (2019) |
| ABIOMED | $29.22 | 1 | $0 (2024) |
| Braintree Laboratories, Inc. | $27.58 | 1 | $0 (2023) |
| Celgene Corporation | $13.58 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.21 | 5 | Janssen Biotech, Inc. ($136.99) |
| 2023 | $134.25 | 7 | AbbVie Inc. ($63.40) |
| 2022 | $62.77 | 1 | Boston Scientific Corporation ($62.77) |
| 2021 | $32.67 | 2 | BOSTON SCIENTIFIC CORPORATION ($32.67) |
| 2020 | $71.10 | 1 | Boston Scientific Corporation ($71.10) |
| 2019 | $494.64 | 5 | Echosens North America, Inc. ($200.50) |
| 2018 | $61.12 | 1 | AbbVie, Inc. ($61.12) |
| 2017 | $162.71 | 3 | AbbVie, Inc. ($141.73) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $98.38 | General |
| Category: Immunology | ||||||
| 06/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $29.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: Immunology | ||||||
| 03/05/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Immunology | ||||||
| 10/09/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Immunology | ||||||
| 08/17/2023 | AbbVie Inc. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Immunology | ||||||
| 04/27/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.58 | General |
| Category: Neuroscience | ||||||
| 04/11/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: GI COLON PREP | ||||||
| 06/29/2022 | Boston Scientific Corporation | Dreamtome RX 49 (Device) | Food and Beverage | In-kind items and services | $62.77 | General |
| Category: Dreamtome_ENDO | ||||||
| 03/23/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/10/2021 | BOSTON SCIENTIFIC CORPORATION | AXIOS (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/19/2020 | Boston Scientific Corporation | EXALT MODEL D CONTROLLER (Device) | Food and Beverage | In-kind items and services | $71.10 | General |
| Category: THERAPEUTIC IMAGING | ||||||
| 12/19/2019 | Boston Scientific Corporation | GENERAL BILIARY DEVICES (Device) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: BILIARY DEVICES | ||||||
| 06/25/2019 | Boston Scientific Corporation | CAPTIVATOR COLD (Device) | Food and Beverage | In-kind items and services | $92.66 | General |
| Category: POLYPECTOMY | ||||||
| 05/23/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $99.82 | General |
| 03/30/2019 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $200.50 | General |
| Category: Elastography | ||||||
| 03/27/2019 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $85.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/12/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $61.12 | General |
| 11/02/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $65.65 | General |
| 05/31/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - HEMOSTASIS (Device) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: HEMOSTASIS | ||||||
| 05/18/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $76.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 377 | 402 | $285,503 | $37,451 |
| 2022 | 9 | 345 | 373 | $197,716 | $32,767 |
| 2021 | 9 | 332 | 352 | $164,313 | $30,467 |
| 2020 | 9 | 318 | 352 | $149,012 | $27,391 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 76 | 78 | $97,656 | $15,551 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $17,646 | $6,036 | 34.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 91 | 94 | $83,028 | $4,737 | 5.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 65 | 70 | $51,240 | $4,214 | 8.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 48 | $10,656 | $3,936 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 42 | $6,258 | $2,737 | 43.7% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 18 | 19 | $19,019 | $239.97 | 1.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 68 | 68 | $66,028 | $12,904 | 19.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 84 | 85 | $64,090 | $4,759 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 37 | $6,828 | $3,647 | 53.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 34 | $9,214 | $3,610 | 39.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 50 | 51 | $33,660 | $2,570 | 7.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 39 | $4,701 | $2,564 | 54.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 26 | $3,718 | $1,457 | 39.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 22 | $2,690 | $1,119 | 41.6% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $6,787 | $137.20 | 2.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 50 | 50 | $48,550 | $10,030 | 20.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 70 | 70 | $52,780 | $5,248 | 9.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 38 | 38 | $10,298 | $3,991 | 38.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 39 | 42 | $27,720 | $3,067 | 11.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 41 | $4,879 | $2,803 | 57.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 42 | $6,006 | $2,338 | 38.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 32 | $3,648 | $1,837 | 50.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 23 | $1,794 | $978.12 | 54.5% |
| 45381 | Injections beneath lining of large bowel, using a flexible endoscope | Facility | 2021 | 14 | 14 | $8,638 | $174.44 | 2.0% |
About Dr. Mark Smith, MD
Dr. Mark Smith, MD is a Gastroenterology healthcare provider based in York, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720086358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Smith, MD has received a total of $1,185 in payments from pharmaceutical and medical device companies, with $166.21 received in 2024. These payments were reported across 25 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,185).
As a Medicare-enrolled provider, Smith has provided services to 1,372 Medicare beneficiaries, totaling 1,479 services with total Medicare billing of $128,076. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location York, PA
- Active Since 07/08/2005
- Last Updated 02/28/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1720086358
Products in Payments
- FibroScan (Device) $200.50
- TREMFYA (Drug) $113.10
- CAPTIVATOR COLD (Device) $92.66
- ENTYVIO (Biological) $85.57
- EXALT MODEL D CONTROLLER (Device) $71.10
- Dreamtome RX 49 (Device) $62.77
- STELARA (Biological) $53.58
- SKYRIZI (Biological) $46.77
- Impella (Device) $29.22
- SUTAB (Drug) $27.58
- GENERAL - HEMOSTASIS (Device) $20.98
- AXIOS (Device) $17.00
- RINVOQ (Biological) $16.63
- GENERAL BILIARY DEVICES (Device) $16.09
- EXALT (Device) $15.67
- ZEPOSIA (Drug) $13.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in York
Dr. Alan Rosen, Md, MD
Gastroenterology — Payments: $7,830
Zaid Alnoah, M.d, M.D
Gastroenterology — Payments: $3,816
Dr. Rajesh Panchwagh, Do, DO
Gastroenterology — Payments: $3,581
Frances Onyimba, M.d, M.D
Gastroenterology — Payments: $3,534
Pin Wang, M.d, M.D
Gastroenterology — Payments: $2,096
Duane Ahlbrandt, M.d, M.D
Gastroenterology — Payments: $1,980